Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Oct 27, 2022; 14(10): 1120-1130
Published online Oct 27, 2022. doi: 10.4240/wjgs.v14.i10.1120
Table 2 Long-term efficacy evaluation after cap-assisted endoscopic sclerotherapy treatment (follow-up in 2020, n = 201), n (%)
Efficacy
Excellent
Good
Poor
χ2
P value
Stage Ⅰ54 (61.4)26 (29.5)8 (9.1)
Stage Ⅱ35 (66.1)13(24.5)5 (9.4)8.900.177
Stage Ⅲ34 (68.0)13 (26.0)3 (6.0)
Stage Ⅳ3 (30.0)3 (30.0)4 (40.0)